MedTrace Logo

Comparison of Lasers in the Treatment of Scars

NCT02988622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-10-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the 1550-nm non-ablative Fraxel laser (referred to as Fraxel Laser in this application) to the ablative 10,600-nm carbon dioxide fractional laser (referred to as CO2 Laser in this application) to determine if one is superior to the other in improving the appearance of scars over a series of three treatments. In addition, the investigators hope to identify a more cost-effective method to improve the appearance of scars caused by surgery or trauma.

Conditions

  • Scar

Interventions

DEVICE

Fraxel Laser

One half of the scar is treated with Fraxel Laser

DEVICE

CO2 Laser

One half of the scar is treated with CO2 Laser.

Sponsors & Collaborators

  • Marta Hemmingson-Van Beek

    lead OTHER

Principal Investigators

  • Pooja Chitogopeker, MD · University of Iowa

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-01-15
Completion
2018-01-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02988622 on ClinicalTrials.gov